Agilent

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Agilent and other ETFs, options, and stocks.

About A

Agilent Technologies, Inc. engages in the provision of application focused solutions for life sciences, diagnostics, and applied chemical markets. It operates through the following segments: Life Sciences and Diagnostics Markets, Applied Markets, and Agilent CrossLab. 

CEO
Padraig Mcdonnell
CEOPadraig Mcdonnell
Employees
18,100
Employees18,100
Headquarters
Santa Clara, California
HeadquartersSanta Clara, California
Founded
1999
Founded1999
Employees
18,100
Employees18,100

A Key Statistics

Market cap
37.17B
Market cap37.17B
Price-Earnings ratio
27.21
Price-Earnings ratio27.21
Dividend yield
0.74%
Dividend yield0.74%
Average volume
3.05M
Average volume3.05M
High today
High today
Low today
Low today
Open price
$135.47
Open price$135.47
Volume
0.00
Volume0.00
52 Week high
$160.27
52 Week high$160.27
52 Week low
$108.35
52 Week low$108.35

Stock Snapshot

As of today, Agilent(A) shares are valued at $132.22. The company's market cap stands at 37.17B, with a P/E ratio of 27.21 and a dividend yield of 74.3%.

During the trading day, Agilent(A) stock saw an opening price of $135.47, a peak of —, and a bottom of —.

Trading volume for Agilent(A) stock has reached 0, versus its average volume of 3.05M.

Over the past 52 weeks, Agilent(A) stock has traded between a high of $160.27 and a low of $108.35.

Over the past 52 weeks, Agilent(A) stock has traded between a high of $160.27 and a low of $108.35.

A News

TipRanks 1h
Agilent initiated with a Neutral at Piper Sandler

Piper Sandler analyst David Westenberg initiated coverage of Agilent (A) with a Neutral rating and $150 price target The firm launched coverage of the life scie...

MarketWatch 3d
Agilent Technologies Inc. stock underperforms Monday when compared to competitors - MarketWatch

...

Agilent Technologies Inc. stock underperforms Monday when compared to competitors - MarketWatch
Simply Wall St 3d
How Investors May Respond To Agilent Technologies Expanding AI-Enabled Lab Solutions And Oncology Diagnostics

In late May and early June 2026, Agilent Technologies reported higher quarterly sales and earnings, raised its fiscal 2026 revenue guidance to US$7.39–US$7.49 b...

How Investors May Respond To Agilent Technologies Expanding AI-Enabled Lab Solutions And Oncology Diagnostics

Analyst ratings

81%

of 21 ratings
Buy
81%
Hold
19%
Sell
0%

More A News

Simply Wall St 7d
A Look At Agilent Technologies Valuation As FDA Approval AI Deal And Earnings Update Draw Focus

Agilent Technologies (A) stock is back in focus after a packed stretch of news, including expanded FDA approval for its PD-L1 diagnostic, a new artificial intel...

A Look At Agilent Technologies Valuation As FDA Approval AI Deal And Earnings Update Draw Focus

People also own

Based on the portfolios of people who own A. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.